Prevention
By Mayo Clinic staffRight now, the cause of monoclonal gammopathy of undetermined significance is unknown, so there is no way to prevent monoclonal gammopathy of undetermined significance and no way to stop it from progressing to a more serious condition.
References
- Blade J. Monoclonal gammopathies of undetermined significance. New England Journal of Medicine. 2006;355:2765.
- Rajkumar SV, et al. Advances in the diagnosis, classification, risk stratification, and management of monoclonal gammopathy of undetermined significance: Implications for recategorizing disease entities in the presence of evolving scientific evidence. Mayo Clinic Proceedings. 2010;85:945.
- Rajkumar SV. Monoclonal gammopathy of undetermined significance. http://www.uptodate.com/home/index.html. Accessed Oct. 19, 2010.
- Monoclonal gammopathy of undetermined significance (MGUS). The Merck Manuals: The Merck Manual for Healthcare Professionals. http://www.merck.com/mmpe/print/sec11/ch144/ch144d.html. Accessed Oct. 21, 2010.
- Wadhera RK, et al. Prevalence of monoclonal gammopathy of undetermined significance: A systematic review. Mayo Clinic Proceedings. 2010;85:933.
- Landgren O, et al. Obesity is associated with an increased risk of monoclonal gammopathy of undetermined significance among black and white women. Blood. 2010;116:1056.
- Mikhael JR (expert opinion). Mayo Clinic, Scottsdale, Ariz. Nov. 12, 2010.

Find Mayo Clinic on